Back to results
US 12,606,632 B2Granted
Anti-CD40 antibodies and methods of use
AssigneeApexigen, Inc.
InventorsYongke Zhang, Guo-Liang Yu, Weimin Zhu
Life of this patent
Estimating the term…
Abstract
The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Claims12
A humanized monoclonal antibody that binds to CD40 and is a CD40 agonist, comprising:
- (i) a heavy chain variable region comprising the VHCDR1 region set forth in SEQ ID NO:
- 3, the VHCDR2 region set forth in SEQ ID NO:4, and the VHCDR3 region set forth SEQ ID NO:
- 5;
- (ii) a light chain variable region comprising the VLCDR1 region set forth in SEQ ID NO:
- 6, the VLCDR2 region set forth in SEQ ID NO:7, and the VLCDR3 region set forth in SEQ ID NO:
- 8;
- and
- (iii) a human IgG1 heavy chain constant region comprising the amino acid sequence set forth in SEQ ID NO:
- 195.
6 more elements
Dependencies are inferred from the claim text.